Saba Capital Management, L.P. sold HQL

March 27, 2025 · Form 4 insider transaction

Saba Capital Management, L.P. sold 32,922 shares of Abrdn Life Sciences Investors at $13.01 per share, a transaction worth $428.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.